Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure.
Identifieur interne : 001C31 ( PubMed/Checkpoint ); précédent : 001C30; suivant : 001C32Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure.
Auteurs : Daniel G. Healy ; Gordon T. Ingle ; Peter BrownSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2009.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Amines, Anticonvulsants, Cyclohexanecarboxylic Acids, gamma-Aminobutyric Acid.
- chemical , analogs & derivatives : gamma-Aminobutyric Acid.
- chemically induced : Myoclonus.
- drug therapy : Kidney Failure, Chronic.
- Humans, Male, Middle Aged.
DOI: 10.1002/mds.22286
PubMed: 19642217
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:19642217Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure.</title>
<author><name sortKey="Healy, Daniel G" sort="Healy, Daniel G" uniqKey="Healy D" first="Daniel G" last="Healy">Daniel G. Healy</name>
</author>
<author><name sortKey="Ingle, Gordon T" sort="Ingle, Gordon T" uniqKey="Ingle G" first="Gordon T" last="Ingle">Gordon T. Ingle</name>
</author>
<author><name sortKey="Brown, Peter" sort="Brown, Peter" uniqKey="Brown P" first="Peter" last="Brown">Peter Brown</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="doi">10.1002/mds.22286</idno>
<idno type="RBID">pubmed:19642217</idno>
<idno type="pmid">19642217</idno>
<idno type="wicri:Area/PubMed/Corpus">001C16</idno>
<idno type="wicri:Area/PubMed/Curation">001C16</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001C31</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure.</title>
<author><name sortKey="Healy, Daniel G" sort="Healy, Daniel G" uniqKey="Healy D" first="Daniel G" last="Healy">Daniel G. Healy</name>
</author>
<author><name sortKey="Ingle, Gordon T" sort="Ingle, Gordon T" uniqKey="Ingle G" first="Gordon T" last="Ingle">Gordon T. Ingle</name>
</author>
<author><name sortKey="Brown, Peter" sort="Brown, Peter" uniqKey="Brown P" first="Peter" last="Brown">Peter Brown</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amines (adverse effects)</term>
<term>Anticonvulsants (adverse effects)</term>
<term>Cyclohexanecarboxylic Acids (adverse effects)</term>
<term>Humans</term>
<term>Kidney Failure, Chronic (drug therapy)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Myoclonus (chemically induced)</term>
<term>gamma-Aminobutyric Acid (adverse effects)</term>
<term>gamma-Aminobutyric Acid (analogs & derivatives)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Amines</term>
<term>Anticonvulsants</term>
<term>Cyclohexanecarboxylic Acids</term>
<term>gamma-Aminobutyric Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>gamma-Aminobutyric Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Myoclonus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Kidney Failure, Chronic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">19642217</PMID>
<DateCreated><Year>2009</Year>
<Month>11</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>01</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>02</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>24</Volume>
<Issue>13</Issue>
<PubDate><Year>2009</Year>
<Month>Oct</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure.</ArticleTitle>
<Pagination><MedlinePgn>2028-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.22286</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Healy</LastName>
<ForeName>Daniel G</ForeName>
<Initials>DG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ingle</LastName>
<ForeName>Gordon T</ForeName>
<Initials>GT</Initials>
</Author>
<Author ValidYN="Y"><LastName>Brown</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>G0400617</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000588">Amines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003509">Cyclohexanecarboxylic Acids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>55JG375S6M</RegistryNumber>
<NameOfSubstance UI="C080245">pregabalin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>56-12-2</RegistryNumber>
<NameOfSubstance UI="D005680">gamma-Aminobutyric Acid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>6CW7F3G59X</RegistryNumber>
<NameOfSubstance UI="C040029">gabapentin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000588">Amines</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000927">Anticonvulsants</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003509">Cyclohexanecarboxylic Acids</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007676">Kidney Failure, Chronic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009207">Myoclonus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005680">gamma-Aminobutyric Acid</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs & derivatives</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>7</Month>
<Day>31</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>7</Month>
<Day>31</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>1</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.22286</ArticleId>
<ArticleId IdType="pubmed">19642217</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Brown, Peter" sort="Brown, Peter" uniqKey="Brown P" first="Peter" last="Brown">Peter Brown</name>
<name sortKey="Healy, Daniel G" sort="Healy, Daniel G" uniqKey="Healy D" first="Daniel G" last="Healy">Daniel G. Healy</name>
<name sortKey="Ingle, Gordon T" sort="Ingle, Gordon T" uniqKey="Ingle G" first="Gordon T" last="Ingle">Gordon T. Ingle</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C31 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001C31 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:19642217 |texte= Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:19642217" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |